Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...
After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad. In ...
GLP-1 agents "have an intricate web of various effects," Al-Aly said in a press briefing. For example, the analysis showed ...
After 48 years on death row, the results of Zeigler’s successful battle for DNA testing could mark a breakthrough.
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Amgen’s LUMAKRAS (sotorasib) and Vectibix (panitumumab) combination has received approval from the US Food and Drug ...
Trump Projects Bravado, and Falsehoods, at Rare Pre-Inauguration Rally President-elect Trump delivered a boastful, campaign-style speech where he railed about illegal immigration and denigrated ...